Comparative Effectiveness In U.S. Will Not Be Like NICE, OMB’s Orszag says
This article was originally published in The Gray Sheet
Executive Summary
White House Office of Management and Budget Director Peter Orszag made it clear that the administration is not looking to build a government entity charged with making cost-effectiveness decisions when reviewing the clinical effectiveness of medical treatments
You may also be interested in...
NICE To Create Single "Evaluation Pathway" For Clinical Technology In UK
The U.K.'s National Institute for Health and Clinical Excellence (NICE) is developing a new work program to improve the process for identifying, evaluating and adopting effective new medical devices and diagnostics
NICE To Create Single "Evaluation Pathway" For Clinical Technology In UK
The U.K.'s National Institute for Health and Clinical Excellence (NICE) is developing a new work program to improve the process for identifying, evaluating and adopting effective new medical devices and diagnostics
Obama Budget Seeks Prior Authorization For Medicare Imaging
President Obama's budget proposal for fiscal year 2010 includes a plan for Medicare to contract with private third parties to pre-review and approve imaging payments on a scan-by-scan basis